Ovariamin tablets dietary supplements, No. 40

As a biologically active food supplement - a source of polypeptides and nucleic acids when:

• acute and chronic adnexitis;

• menstrual irregularities;

• functional ovarian failure;

• anovulatory syndrome;

• somatovegetative and psychoemotional manifestations of climacteric syndrome;

• ovarian hyperandrogenism;

• hormone replacement therapy with estrogen-containing drugs;

• in the pre- and postoperative period with gynecological operations;

• in geriatric practice.

OvariaminЃ is recommended to be taken orally 15-20 minutes before meals with water without chewing.

Adults are prescribed 1-3 tablets. 2-3 times / day

Duration of use is 10-14 days. In chronic pathology, it is optimal to repeat the course in 3-6 months.

Enteric-coated tablets from light cream to cream color, round, 7 mm in diameter, weighing 0.155 mg; the presence of a specific smell is possible.

1 tab.

ovariamine powder 10 mg *

* a complex of polypeptides and nucleic acids obtained from the ovaries of cattle and pigs.

Excipients : lactose (filler), granulated sugar (thickener), potato starch (baking powder), calcium stearate (anti-caking agent), methacrylic acid copolymer dispersion (enteric coating), propylene glycol (emulsifier).

• individual intolerance to the components of the product;

• pregnancy;

• period of breastfeeding.

Enteric-coated tablets from light cream to cream color, round, 7 mm in diameter, weighing 0.155 mg; the presence of a specific smell is possible.

1 tab.

ovariamine powder 10 mg *

* a complex of polypeptides and nucleic acids obtained from the ovaries of cattle and pigs.

Excipients : lactose (filler), granulated sugar (thickener), potato starch (baking powder), calcium stearate (anti-caking agent), methacrylic acid copolymer dispersion (enteric coating), propylene glycol (emulsifier).

Properties

The components for Ovariamin, obtained from the ovaries of cattle, are a complex of proteins and nucleoproteins that have a selective effect on the cells of a woman's ovaries, which contributes to the normalization of their hormone- and gamete-forming functions.

Clinical studies of the effect of Ovariamin were carried out in 180 women with climacteric syndrome of various etiologies (involutionary, postoperative), as well as with ovarian wasting syndrome. The effectiveness of the use of Ovariamin was assessed by the dynamics of complaints, data from laboratory, functional and instrumental studies.

In a laboratory study of the parameters of the neuroendocrine system, a significant decrease in the level of FSH in the blood was noted, as well as a tendency towards a decrease in ACTH and TSH. The revealed changes in the hormonal status of patients against the background of the use of Ovariamin correlate with the positive dynamics of the clinical picture, which may indicate an increase in the functional activity of the glandular tissue of the ovaries.

In patients with ovarian depletion syndrome, the use of Ovariamin in 58% of cases caused the menstrual cycle to normalize, helped to reduce the asthenovegetative and asthenoneurotic manifestations of the disease.

The data of laboratory and instrumental studies indicate an increase in the size of the ovaries and an increase in their steroidogenic function, a decrease in the gonadotropic function of the adenohypophysis.

Analysis of the results of clinical trials allows us to conclude that the course use of Ovariamin has a normalizing effect on the cellular metabolism of the ovaries, helps to normalize the process of formation and maturation of follicles and to restore neurohumoral mechanisms of regulation of menstrual and reproductive functions.

OvariaminЃ is recommended to be used to accelerate the recovery of ovarian functions in various forms of ovarian dysfunction, incl. with negative manifestations of menopause in women. It is also recommended for older women to maintain ovarian function.

Clinical studies on the use of Ovariamin were carried out in 31 patients of various reproductive ages with a low ovarian reserve and a period of hormonal infertility from 2 to 7 years. In the dynamics of treatment, the hormonal profile, the results of functional diagnostics tests before assistive technologies were assessed. The content of hormones (FSH, LH, estradiol and progesterone) in the blood serum was determined by radioimmunoassay.

After the use of Ovariamin in women under the age of 25-30, who had previously undergone surgery (mainly ovarian resection), there was a good hormonal response to stimulation of the ovaries before in vitro fertilization (IVF). A significant improvement in the quality of life of patients was revealed: a decrease in fatigue, an improvement in memory, psychoemotional stability in stressful situations, a normalization of appetite, an increase in muscle tone and a decrease in the depressive radical. It should be noted a pronounced economic effect in the management of this category of patients due to shorter stimulation schemes for IVF and, especially, when replacing IVF with insemination.

It is advisable to use OvariaminЃ before assisted reproductive technologies in women after various operations on the ovaries under the age of 30 years with FSH levels below 10 mIU / ml before in vitro fertilization, as well as prescribe to patients after 35 years with FSH values ??above 10 mIU / ml for in vitro fertilization.

OvariaminЃ is a natural product that does not contain preservatives, dyes or fragrances.

Scope of the product OvariaminЃ

As a biologically active food supplement - a source of polypeptides and nucleic acids when:

• acute and chronic adnexitis;

• menstrual irregularities;

• functional ovarian failure;

• anovulatory syndrome;

• somatovegetative and psychoemotional manifestations of climacteric syndrome;

• ovarian hyperandrogenism;

• hormone replacement therapy with estrogen-containing drugs;

• in the pre- and postoperative period with gynecological operations;

• in geriatric practice.

  Recommendations for use

  OvariaminЃ is recommended to be taken orally 15-20 minutes before meals with water without chewing.

  Adults are prescribed 1-3 tablets. 2-3 times / day

  Duration of use is 10-14 days. In chronic pathology, it is optimal to repeat the course in 3-6 months.

  Side effects

  The product has no side effects.

  Contraindications

  • individual intolerance to the components of the product;

  • pregnancy;

  • period of breastfeeding.

  Application during pregnancy and lactation

  Use during pregnancy and lactation is contraindicated.

  special instructions

  It is not a drug.

  It is recommended to consult a doctor before use.

  Storage conditions of the product OvariaminЃ

  The product should be stored in a dry place out of the reach of children at a temperature of 2 ? C to 25 ? C.

  Shelf life of the product OvariaminЃ

  Expiration date - 3 years from the date of manufacture.